Rare diseases
Investigational molecules
Locations
Back to France1 504 clinical trials in Toulouse, France across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study of Anifrolumab for Children and Teens with Moderate to Severe Lupus
FranceStudy of AZD5863 for Adults with Advanced or Metastatic Solid Tumors
FranceStudy on Roxadustat for Treating Anemia in Children with Chronic Kidney Disease
FranceStudy on Elacestrant for Treating ER+/HER2- Breast Cancer in Patients with ctDNA Relapse
FranceStudy on Personalized Antithrombotic Therapy with Acenocoumarol, Phenprocoumon, and Apixaban for Patients with Aortic Valve Stenosis Post-TAVI
FranceStudy on EXL01 to Prevent Recurrence of C. difficile Infection in High-Risk Patients
FranceStudy on Letermovir and Valganciclovir for Treating CMV Infections in Kidney Transplant Patients
FranceStudy on Sotatercept for Children with Pulmonary Arterial Hypertension Receiving Standard Care
FranceStudy on Lasofoxifene, Fulvestrant, and Abemaciclib for Advanced Breast Cancer in Women and Men with ESR1 Mutation
FranceStudy on Long-Term Safety of Inclisiran for Patients with Familial Hypercholesterolemia Who Completed Previous Adolescent Studies
FranceStudy of Fluoroestradiol F-18 and Biomarkers for Women with ER-Positive HER2-Negative Metastatic Breast Cancer After CDK4/6 Inhibitor Therapy
FranceStudy on Early Detection of Triple-Negative Breast Cancer Relapse Using 68Ga-FAPI-46 for Patients at High Risk
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative studies focusing on heart disease treatment, including trials for TTR amyloidosis and prevention of heart failure. Advanced therapeutic approaches using novel compounds like baxdrostat in combination with established medications.
Comprehensive cancer research targeting multiple types of malignancies, including head and neck cancer, gastric cancer, and advanced pancreatic cancer. Novel approaches using targeted therapies and immunotherapy combinations.
Advanced research in neurodegenerative conditions and movement disorders, including studies on frontotemporal dementia, essential tremor, and traumatic brain injury outcomes.
Studies investigating new treatments for inflammatory diseases, including innovative approaches for Crohn's disease, psoriatic arthritis, and myasthenia gravis.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
